Showing results (521-530 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|March 22, 2012
From injection therapies to natalizumab: views on the treatment of multiple sclerosisRoberto Bomprezzi, Darin T Okuda, Yazan J Alderazi, et al.Therapeutic Advances in Neurological Disorders|March 22, 2012
Health-related quality of life as an outcome variable in Parkinson's diseasePablo Martinez-Martin, Mónica M KurtisTherapeutic Advances in Neurological Disorders|March 22, 2012
Neuroimaging of motor neuron diseasesJan Kassubek, Albert C Ludolph, Hans-Peter MüllerTherapeutic Advances in Neurological Disorders|January 26, 2012
Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?Rupam Borgohain, Rukmini Mridula Kandadai, Afshan Jabeen, et al.Therapeutic Advances in Neurological Disorders|July 19, 2011
Disease-modifying treatments for Alzheimer's diseaseDaniela Galimberti, Elio ScarpiniTherapeutic Advances in Neurological Disorders|July 19, 2011
Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical reviewAmer M Awad, Ellen Marder, Ron Milo, et al.Therapeutic Advances in Neurological Disorders|June 23, 2011
Treatment of walking impairment in multiple sclerosis with dalfampridineAndrew R BlightTherapeutic Advances in Neurological Disorders|June 23, 2011
Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosisElke Voss, Peter Raab, Corinna Trebst, et al.Therapeutic Advances in Neurological Disorders|June 23, 2011
Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathyMin-Suk Yoon, Andrew Chan, Ralf GoldTherapeutic Advances in Neurological Disorders|October 20, 2011
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosisAaron Boster, Mary Pat Bartoszek, Colleen O'Connell, et al.Pageof 108